TGFB1 and triple-negative breast carcinoma: Recently, TGF-β-treated endothelial cells were reported to induce PAI-1 secretion and promote metastasis of triple-negative breast cancer cells [31], illustrating the potential of PAI-1 as a target of breast cancer therapies.